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Until now direct neurochemical measurements during memory tasks have not been
accomplished in the human basal ganglia. It has been proposed, based on both functional
imaging studies and psychometric testing in normal subjects and in patients with
Parkinson’s disease (PD), that the basal ganglia is responsible for the performance of
feedback-contingent implicit memory tasks. To measure neurotransmitters, we used
in vivo microdialysis during deep brain stimulation (DBS) surgery. We show in the
right subthalamic nucleus (STN) of patients with PD a task-dependent change in the
concentrations of glutamate and GABA during an implicit memory task relative to
baseline, while no difference was found between declarative memory tasks. The five
patients studied had a significant decrease in the percent concentration of GABA and
glutamate during the performance of the weather prediction task (WPT). We hypothesize,
based on current models of basal ganglia function, that this decrease in the concentration
is consistent with expected dysfunction in basal ganglia networks in patients with PD.
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INTRODUCTION
Parkinson’s disease (PD) has been the most widely studied
movement disorder. Various modalities have been used to
quantify the dysfunction of both the nigrostriatal and the meso-
cortical systems in PD. Although a variety of currently available
“non-invasive” methods such as fMRI, Positron Emission
Tomography, Single-photon Emission Computed Tomography
(SPECT) and most recently DaTscan imaging allow for mea-
suring changes in brain metabolism in relationship to PD
(Niethammer et al., 2012), these changes are linked indirectly
to transmitter release. Moreover, these neuroimaging methods
have the limitation of being more “qualitative” than “quanti-
tative”. In contrast, invasive techniques such as microdialysis
provide direct and quantitative measurements of the chemical
constituents of fluid in the extracellular space of the brain.
Neurosurgery provides an opportunity to safely insert a micro-
dialysis catheter into a region of interest enabling researchers to
study task-contingent modulation of neurotransmitters in the
human brain in patients undergoing neurosurgical intervention
(Fried et al., 1999). We implemented microdialysis in deep
brain stimulation (DBS) surgeries, an increasingly common
treatment option for patients with PD. The measurement of
both glutamate and GABA in this study provides a neu-
rochemical atlas of subthalamic nucleus (STN) function in
patients with PD. Our results can be directly correlated with
future functional neuroimaging studies of STN metabolism dur-
ing implicit memory tasks in both normal subjects and PD
patients.
DBS involves placement of electrodes into specific regions
of the brain, allowing the delivery of electrical impulses, and
recently was shown to be one of the best treatment options
available for individuals with advanced PD (Weaver et al., 2009).
A microdialysis catheter can be placed in this same region as
a DBS electrode, providing an opportunity for researchers to
examine the neurotransmitter correlates of memory function in
PD, without any additional damage to brain tissue. This study
using intraoperative-microdialysis allowed for the first time in
the human brain (i) to assess the modulation of transmitter
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FIGURE 1 | The basal ganglia circuitry. The scheme represents the main
pathways of the BG in the healthy brain with respect to declarative and
implicit memory functions. Blue arrows represent glutamatergic, red
arrows GABAergic and magenta arrows represent dopaminergic
connections. Direct, indirect and hyperdirect pathways are indicated.
release during declarative and implicit memory tasks; and (ii)
study neuro-pharmacological effects of PD on memory functions.
Nevertheless, the interpretation of such data requires a good
understanding of the neural circuitry and, based on the well-
established scheme of direct, indirect and hyper-direct pathways
of the basal ganglia (BG) system (Figure 1) we were able to
make assumptions about the neurotransmitter levels during an
implicit memory task performed by normal subjects (Figure 3).
This assumption was used to predict changes in neurotransmit-
ter levels in the STN under PD assuming correlation with its
known effect on implicit memory performance. Nevertheless,
because molecular samples cannot be ethically collected from
a normal population, the net contribution of the pathology to
the neurochemistry of BG could not be completely assessed.
Therefore, predictions concerning the neurotransmitter release
in the healthy BG during implicit memory tests could not be
tested.
The activity dynamics in the BG is best understood in terms
of excitation, inhibition and disinhibition (Figure 1). The most
prevalent excitatory and inhibitory neurotransmitters in the BG
are glutamate (GLU) and gamma-amino butyric acid (GABA;
Sian et al., 1999). In this study, we took microdialysate from five
right handed patients with PD during DBS placement in the non-
dominant (right) STN and later analyzed it for the concentrations
of glutamate and GABA. Intraoperatively, patients participated
in cognitive testing during the collection of the microdialysis
samples. Patients performed the weather prediction task (WPT)
with immediate feedback, known to engage implicit memory, and
word recollection tasks to engage declarative memory (Knowlton
et al., 1994). We hypothesized that there would be a change in
the relative concentrations of these neurotransmitters in the STN
during the WPT relative to declarative memory task, and this
change is opposite of what is expected to be in healthy subjects,
representing involvement of the STN in this form of implicit
memory processing and its pathology.
FIGURE 2 | Diagram of cortical and BG activity during a declarative
memory task in a healthy control. The thickness of arrows represents the
theoretical expected concentration change relative to the baseline depicted
in Figure 1. The gray-shaded area represents the part of the BG circuitry
involved in declarative memory task. Green shadows represent activation
and the red shadow represents suppression of the structures.
PARKINSON’S DISEASE (PD) AND LEARNING/MEMORY
PD patients have significant deficits on tests of learning and
memory. These deficits are most severe in implicit memory
tasks (Packard and McGaugh, 1992; Knowlton et al., 1996).
The anatomical substrates of declarative and implicit memory
have been and continue to be studied. The central role of the
basal ganglia in implicit memory has been further supported
with the WPT when the performance of amnesic patients and
Parkinson’s patients were compared as they performed memory
tasks (Gluck and Bower, 1988; Poldrack et al., 2001). Parkin-
son’s patients had significant difficulties with the WPT while
amnesic patients displayed difficulties recalling “facts” about
the same task. As the pathology in PD lies within the basal
ganglia (dopamine producing cells of substantia nigra), it was
concluded that the basal ganglia is involved in implicit memory
(Knowlton et al., 1996). This hypothesis has been supported
using fMRI to show increased activity in the basal ganglia
during motor memory or habit learning (Rauch et al., 1997;
Poldrack et al., 1999). The WPT, originally thought to engage only
implicit memory, has been used in many studies and explored
to further understand its cognitive engagement. The perfor-
mance of PD patients on the WPT was refined further through
experiments suggesting that performance is impaired only when
feedback from responses are provided and if such feedback is
provided immediately (<6 s) (Shohamy et al., 2004a; Foerde
and Shohamy, 2011). For example, if the WPT is modified by
removing trial-by-trial feedback or if the feedback is delayed, PD
patients perform near controls. Additionally, evidence suggests
that the medial temporal lobe (MTL) is engaged early during
WPT in healthy controls and PD patients, diminishing rapidly
with continued training (Poldrack et al., 2001; Moody et al.,
2004).
In retrospect, it is not surprising that the WPT requires declar-
ative memory to some extent, especially at the start of a new task.
The failure of most PD patients to transition from a MTL mode
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FIGURE 3 | Diagram of cortical and BG activity during an implicit
memory task in a healthy control. The expected changes in STN are the
increased concentration of GABA and the decreased concentration of
glutamate. The thickness of arrows represents the theoretical expected
concentration change relative to the baseline depicted in Figure 1. The
gray-shaded area represents the part of the BG circuitry involved in implicit
memory task. Green shadows represent activation and red shadows
represent suppression of activity in the structure.
of memory to a BG mode still leaves many questions unanswered
concerning the interaction between these two modes of memory
and their control (Foerde and Shohamy, 2011). While current
research has not clarified the pattern of interaction between BG
and MTL modes of memory, evidence exists to support model
of competition and cooperation depending on the specific task
(Poldrack et al., 2001; Dickerson et al., 2011).
The BG’s involvement in implicit memory is further corrob-
orated by the fact that DBS stimulation in STN differentially
affects declarative and implicit memory performance by impair-
ing declarative memory, whereas improving implicit memory
(Hälbig et al., 2004). Hence, the WPT task should elicit a strong
response in the healthy circuitry of STN (Figure 3) and is expected
to be reversed in PD (Figure 4), explaining the implicit memory
deficit. With the lack of direct neurochemical evidence in support
of the above hypothesis we performed microdialysis in the STN
on PD patients during WPT.
Most studies of implicit memory have emphasized the role of
the caudate, globus pallidus, and putamen, but the STN has not
been extensively studied, despite it being recognized as a critical
structure within the basal ganglia (Redgrave et al., 2010). The
STN is primarily composed of neurons containing glutamate. It
contains sub-regions within, organized regionally, that mediate
limbic, associative, and sensory-motor functions. It is the ventro-
medial regions that comprise the limbic and associative territories
(Parent and Hazrati, 1995; Shink et al., 1996; Joel and Weiner,
1997). The dorsal-lateral aspect of the STN is targeted with DBS
to treat the motor symptoms (tremor, rigidity and bradykniesia)
of PD. In newer models of BG connectivity the STN boasts
efferent connections to at least the Internal Globus Pallidus (GPi)
and Substantia Nigra pars reticulata (SNr), Substantia Nigra pars
compacta (SNc) and Ventral Tegmental Area (VTA), and the
Globus Pallidus Externa (GPe; Redgrave et al., 2010). Additionally,
FIGURE 4 | Diagram of cortical and BG activity during an implicit
memory task in a Parkinson’s patient. The expected changes in STN are
the decreased concentration of GABA and the increased concentration of
glutamate. The meanings of arrows and shadows are the same as in
Figure 3.
it receives projections from the GPe, SNc and VTA, thalamus, and
the cortex (Redgrave et al., 2010).
Microelectrode recordings from patients with PD have
revealed that the STN is hyperactive, with baseline firing rates
of 35–50 Hz, and exhibits abnormal synchronized oscillations
(Hutchison et al., 1998; Levy et al., 2002; Sterio et al., 2002).
Hyperactivity of the STN in PD has become a hallmark of
present models of basal ganglia dysfunction in PD, where the
lack of dopamine causes the STN to fire without a functional
“brake” (GABA) from the GPe through the indirect pathway
(Figure 4; Smith et al., 1990; Bevan et al., 1997, 2007). These
effects are theorized to produce the commonly seen signs and
symptoms of PD, such as bradykinesia and akinesia. Additionally,
the STN has a unique position in BG function by receiving direct
cortical (Glu) input via the “hyperdirect” pathway (Figure 1).
This allows for a rapid response of the STN to excite the pal-
lidum, which would further inhibit the thalamus (Nambu et al.,
2002).
It is now well established that dopamine plays a prominent
role in learning by modulating excitatory and inhibitory cortico-
striatal projections. Facilitating this dynamic are the individual
dopamine receptors, D1 and D2. D1 is known to be expressed
predominantly on the medium spiny neurons (MSN) in the
striatum that project to the GPi, comprising the direct path-
way (Figure 1). D2 expression is relegated to the MSNs that
project to the GPe, which is recognized as the indirect pathway
(Figure 1). Additionally, these cells are also known as Go and No-
Go cells, respectively, due to the function of the direct pathway
to disinhibit and the indirect pathway to further inhibit the GPi
from the striatum. Through its effects on Go and No-Go cells
in the striatum, evidence is mounting that DA increases the
signal-to-noise ratio of striatal cells excited by cortico-striatal pro-
jections, essentially highlighting rewarding associations (Nicola
et al., 2000). Additionally, dips in tonic levels of DA provide a
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mechanism of weakening such relationships, dissociating unre-
warding associations (Clark et al., 1987).
Computational research is beginning to tackle the precise role
of this circuitry in implicit memory formation by explaining
how pathological loss of dopaminergic neurons leads to implicit
memory dysfunction in PD patients (Frank, 2005). Previous
studies have demonstrated an unusual effect of DA-replacement
therapy in PD patients (Cools et al., 2001). While “unmedicated”
patients were found to perform poorly on implicit memory tasks
and nearly normally on explicit memory tasks, medicated patients
were found to perform better on implicit memory tasks but worse
on explicit tasks. As suggested by computational modeling, the
reduced dynamic range of DA is at least somewhat responsible for
the underlying pathology (Frank, 2005).
Accordingly, through an updated model of BG circuitry shown
in Figure 1, we attempted to predict the neurochemical sta-
tus of the STN during explicit and implicit memory forma-
tion in PD patients. Through the hyperdirect pathway, the STN
receives glutamatergic input from temporal/prefrontal cortical
areas (Figures 1 and 2) associated with the declarative mem-
ory. This excitatory input may function to keep the glutamate
concentration in the STN higher during declarative memory
tasks than it is during implicit tasks. Proposed characteriza-
tion of the hyperdirect pathway provides at least two possible
effects on relative levels of Glu during the WPT and declara-
tive tasks. The short temporal nature might prove difficult to
detect relative changes in concentration during microdialysis
(Nambu et al., 2002). Another possibility is that because PD
patients are known to utilize declarative memory even when
presented with tasks that are more optimally completed with
implicit memory, either due to inability or compensation, it
is possible that the hyperdirect pathway frequently engages the
STN, which would persistently reinforce declarative memory
(Shohamy et al., 2004b). Chronic engagement of the MTL, and
corresponding inhibition of STN, might provide a milieu of
relatively excessive Glu. Enforcing an implicit memory task could
provide a short respite to glutamatergic excitation. Addition-
ally, the level of GABA is expected to be slightly higher or the
same during declarative memory, which is mostly driven by the
recently discovered feedback control from the GPe (Nambu et al.,
2000).
During implicit memory tasks, the BG is driven by an input
from a corticofugal system that is anatomically and function-
ally distinct from the declarative memory system (Figure 3).
The corticofugal input derives from the posterior orbitofrontal,
anterior insular cortex as well as the posterior medial prefrontal
anterior cingulate cortex that project exclusively to striosomes in
medial and ventral caudate nucleus (Eblen and Graybiel, 1995).
Normal engagement of a task requiring implicit memory should
disinhibit thalamic activity through the direct pathway and release
activation of the GPi through the indirect pathway. In this way, the
expectation is that the STN will experience increased GABAer-
gic stimulation by the GPe and increased Glu via proportional
feedback from thalamic projections in healthy patients. In PD
patients, we predict that the lack of potentiation by the SNc
results in abnormal hyperactivity of the No-Go MSNs from the
striatum to the GPe, resulting in a hyperactive STN and reduced
glutamatergic feedback from the thalamic projections. Thus, we
expected to find reduced GABA and Glu in the STN during the
WPT in PD patients.
MATERIALS AND METHODS
PATIENT SELECTION
Five patients (n = 5) with medically refractory PD or those who
experienced intolerable side effects from medications are appro-
priate candidates for DBS. Patients underwent a comprehensive
neuropsychological evaluation to rule out dementia and psychi-
atric disease. Those without contraindications for DBS surgery
were told of the risks and benefits of the DBS operation. Patients
who decided to proceed with the operation were told of the
Institutional Review Board (IRB) approved intra-operative study.
Informed consent was obtained. Prior to surgical intervention,
patients were briefed about the study and told that they could
withdraw from the research at any time without any penalty or
consequence. Approval was obtained from the local Institutional
Review Board.
DEEP BRAIN STIMULATION PROCEDURE
Twenty-four hours prior to DBS surgery, patients discontinued all
medications used to treat their PD. Deep brain stimulation pro-
cedures were performed stereotactically (Medtronic-NeXframe)
by the same neurosurgeon, author Robert J. Buchanan (RJB).
Patients received a high-resolution 3T MRI scan with a stereo-
tactic bone/skull fiducial system. The coordinates of the human
STN were established in three-dimensional Cartesian coordinate
system, x, y and z. Stereotactic targeting of the right STN was
accomplished with a combination of atlas coordinates (“indirect
method”) and the patient’s MRI images (“direct method”), in
addition to real-time single cell recordings intra-operatively. In
the operating room, the patient was placed in a comfortable
sitting/lounge chair position on the operating table. A short-
acting sedative (propofol) was administered. The patient was
then covered with blankets to maintain ambient temperature
(98.6◦C). The entry points of the skull were determined with the
use of the NeXframe System. The areas were infiltrated with 1%
lidocaine and an incision was made in a curvilinear fashion. A
right-sided burr hole was then made in the skull with the use
of a high-speed pneumatic drill. The NeXframe (Medtronic) was
attached to the patient’s skull, and then registered to the frameless
image guided stereotactic system (BrainLab). The cannula and
microelectrode were placed within the “Microelectrode drive”,
which lowers the electrode by millimeter fractions into the brain
towards the STN. The microelectrode provided the team with
single cell recordings from brain regions during the descent to
the target (STN). An array of three microelectrodes was used
to somatotopically map the STN. During the microelectrode
recordings, propofol was discontinued. The dorsolateral part of
the nucleus represents the motor territory and is the surgical
DBS target. The microelectrode track that revealed the longest
(at least 5 mm of STN cell activity) was chosen for placement
of the DBS electrode. The microelectrode track that was most
medial and ventral to that track, which also clearly had STN cell
activity, was chosen for the microdialysis experiment. The ventral
and medial regions of the STN are likely to be association and
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limbic areas, respectively, rather than motor (Parent and Hazrati,
1995; Middleton and Strick, 2000). The microdialysis catheter
(CMA, Boston) was placed into the STN based on techniques and
coordinates described previously.
After the STN target was located and catheter placement
accomplished, there was a 45 min period of microdialysis “wash-
out” to achieve steady state baseline measurements of GABA
and GLU. Next, neurotransmitter samples were obtained every
5 min while patients were administered cognitive tasks. Tasks
were separated by one sample collection each. Following the
completion of the research protocol, the microdialysis catheter
was removed and the DBS procedure was completed as per usual.
MICRODIALYSIS
The microdialysis equipment was made by CMA Microdialysis
Corporation, specially designed for use in human brain tissue
in clinical settings. The outer diameter of the shaft of the probe
is 0.67 mm. The diameter of the microdialysis membrane is
0.5 mm. Both of these diameters are smaller than the diameter
of the standard surgical cannula (1.3 mm) that is used to carry
the microeletrode down to the target. The cannula has been
custom designed to accommodate the outer diameter of the deep
brain-stimulating electrode, which is 1.27 mm. The length of the
catheter is 200 mm and the length of the dialysis membrane is
5 mm. The microdialysis catheter was placed into the STN of
the non-dominant hemisphere (right side in all cases) following
a previously made track.
The microdialysis pump device (CMA 107) was set at a flow
rate of 5 ul/min for this experiment. The CMA 142 “Microfraction
Collector” was used to collect the dialysate. All equipment was
supplied by the manufacturer in a sterile fashion. The sterile
pyrogen free PBS solution was used as the perfusate contained in
grams/liter, NaCL 8, KCL 0.2, CaCL2 × 2 20 0.132, MgCl2 × 6
H20 0.1, Na2HPO4 1.15, KH2PO4 0.2 at a pH of 7.4. The levels
of the desired neurotransmitters in the dialysate were analyzed
by high performance chromatography (HPLC). Our technology
enabled measurements of the neurotransmitters to be made in the
nmol/L to micromole/L range.
QUANTIFICATION OF GABA AND GLUTAMATE
GABA and Glutamate were quantified using isocratic HPLC with
electrochemical detection. Briefly, microdialysis samples collected
as described above were mixed with a derivatizing reagent to
prepare o-phthaldehyde (OPA) derivatives of GABA, glutamate,
and homoserine (internal standard). The mixture was prepared
using an ESA 542 autosampler exactly 1 min before injection
into the HPLC system (20 µl of dialysate and 15 µl of working
derivatizing reagent). The derivatizing reagent contained 27 mg of
OPA dissolved in 1 ml methanol, 9 ml of 100 mM sodium tetrab-
orate and 5 µl of β-mercaptoethanol. Twenty-seven µl of final
sample were injected into the HPLC. Glutamate, homoserine, and
GABA eluted at 2.0, 5.1, and 14.6 min, respectively. GABA and
glutamate were quantified by comparing peak area ratios of these
compounds to homoserine against the linear regression of ratios
of a set of calibrators from 0.1 to 500 ng/ml. The concentration of
GABA and glutamate was expressed in ng/ml.
The mobile phase consisted of 27%(v/v) methanol, 50 µM
ethylenediamine tetra-acetic acid (EDTA), 75 mM phosphoric
acid (pH 6.75 with NaOH), and Milli-Q water. The flow rate of
the mobile phase was 1 ml/min and the column temperature was
30◦. The HPLC system consisted of an ESA 584 pump, ESA 542
autosampler, Spherisorb C18 column (3 µ, 4.6× 100 mm), and a
Coulochem III detector equipped with a 5014B detector cell. The
detector was set at 150 mv on E1, 550 mv on E2, and included a
guard cell set at 650 mv.
DECLARATIVE MEMORY TASK
Patients performed a verbal learning task in which they were
read a list of words, and asked to repeat them back. The list
was repeated several times. Following the implicit memory task
(approximately 20 min later), the patients were asked to recall
the list of words read to them prior to the implicit memory task
(delayed recall).
IMPLICIT MEMORY TASK
Patients performed an implicit memory task previously described
in the literature (Knowlton et al., 1996; Moody et al., 2004).
Patients were oriented to the task prior to administration. The
task is frequently referred to as the WPT/Game (Gluck and Bower,
1988). There are four cues in the task, which are represented
by cards with geometric shapes, and these cues predict one of
two outcomes approximately 60–85% of the time. Subjects see
a set of cues on a computer screen and their task is to “guess”
whether the cues predict “sun” or “rain”. Each of these cues is
independently and probabilistically related to the outcome, and
the two outcomes occur equally often. If they make a correct
response they hear a “high” tone and see a smiling face, and
if they predict incorrectly they hear a “low” tone and see a
frowning face. The probabilistic nature of this task appears to
encourage optimal play through an implicit pathway and likely
parallels the gradually acquired habit learning tasks that are
performed by experimental animals. The total task time was
approximately 10 min. We calculated the total scores from the
first to last trial (maximum 100 trials) in the subject’s average
score.
STATISTICAL ANALYSIS
Paired t-tests comparing the percent change of GLU and GABA
levels from a baseline during the implicit and declarative memory
task were performed, where baseline was computed as the average
of the previous and subsequent measurements taken at rest. SAS
version 9.2 was used for all calculations.
RESULTS
It has been demonstrated in the literature that patients with PD
have difficulty learning the WP task (Knowlton et al., 1996).
Our patients followed the same trend (Table 1). As a whole, our
patients scored 52.8%, no better than chance and significantly
worse than the healthy average (68.2%, Knowlton et al., 1994
and 62.8%, Gluck et al., 2002). The difference relative to age
matched healthy control was significant no matter which study
we are comparing it to (mean = 68.2%; SD = 7.36; Student
t(39,5) =−4.503; p < 0.001 (Knowlton et al., 1994); mean = 62.8%;
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Table 1 | Nondeclarative task (ND) and declarative memory recall test
(D1, D2) performance by patient in percentage correct.
Patient ND D1: Trial 1 D1: Trial 2 D1: Trial 3 D2 (20 min)
1 61.9% 42% 58% 42% 25%
2 62.0% 25% 58% 83% 67%
3 54.0% 58% 92% 75% 75%
4 43.0% 33% 75% 58% 58%
5 43.2% 67% 67% 58% 75%
Average 52.8% 45% 70% 63% 60%
Table 2 | 95% confidence intervals of percent change of
neurotransmitter from baseline for each memory test.
Test Glutamate GABA
D1 (−87.12, 22.79) (−71.25, 20.68)
WP (−86.60, −4.07) (−104.50, −41.23)
D2 (−55.11, 108.30) (−83.29, 77.05)
SD = 7.2, difference: Student t-test t(32,5) = −2.875; p = 0.007)
(Gluck et al., 2002).
The results of the subjects during the declarative memory task
are shown in Table 1. Patients averaged 59% recall overall during
the first three trials (D1) and 60% at 20 min (D2). There were no
statistically significant differences.
Results of microdialysis during each of the tasks in their
order of sequence are depicted in Figure 5 with 95% confidence
intervals shown in Table 2. During the first and second declarative
tasks, the percent change of glutamate and GABA concentrations
from baseline (computed as the average of prior and subse-
quent concentrations) demonstrated no statistically significant
difference, separately or when combined. In contrast, the percent
change of concentrations of glutamate and GABA were found to
be lower during the WPT (P < 0.038 and P < 0.0031). The change
during the WPT was 30 and 55% of baseline for glutamate and
GABA, respectively.
DISCUSSION
DECLARATIVE TASK
During the declarative memory task, we hypothesized that gluta-
mate released from the cortical regions (via hyperdirect pathway)
would be expected to increase from baseline levels to stimulate the
STN in healthy subjects, as illustrated in Figure 2. The input from
cortical levels would potentiate the indirect pathway, dampening
the basal ganglia (Aron and Poldrack, 2006). This is a cognitive
version of “blocking” an initiation of the “Go” response. STN
excitation would lead to a stimulation of the GPi. The GPi, in turn,
would cause further inhibition of those regions of the thalamus
anatomically connected to BG memory systems. Additionally,
while overall activity in the STN is predicted to be relatively
increased, the exact contribution from inhibitory and excitatory
input is less clear. With newer models of BG circuitry highlighting
feedback from the STN to the GPe, we predicted mild dampening
of the STN by the GPe (Redgrave et al., 2010). Acknowledging
tremendous uncertainty about the overall dynamics in the rest of
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FIGURE 5 | Average percent change of Glu and GABA from baseline
during declarative tasks (D1, D2) and WTP with 95% confidence
intervals.
the BG during declarative memory formation in healthy adults,
we cautiously predicted relatively increased or unchanged GABA
within the STN during a declarative memory task in a healthy
control.
In PD patients, reduced dopaminergic input to the striatum
provides baseline hyperactivity of the STN. During a declara-
tive memory task, the hyperdirect pathway would function as
in healthy patients by providing increased glutamatergic input,
but compensatory engagement of the declarative memory system
might wash-out any marginal increase. The effect of maintaining
or engaging declarative memory on the GPe, and thus the STN, is
unclear. In our patients, we found no noticeable average percent
change in Glu or GABA from baseline during either declarative
memory task.
Washout from compensatory engagement of the MTL is one
possible explanation for our findings. This could be visualized as
asking a patient already engaging the MTL to continue to engage
the MTL. We observed large variation in Glu, which could be due
to a variety of forces. Our analysis of newer models of BG circuitry
does not highlight the importance of GABA activity in the STN
during declarative memory. This may explain our finding of no
significant change in GABA, where it may take on a wide range of
values without direct effect.
IMPLICIT TASK
In contrast, the WPT activates the cortico-striatal pathway, which
converges with the nigro-striatal pathway from SNc. SNc input
enables feedback-contingent learning by immediate D2 release to
reinforce habit-memory (Schultz, 2013). The two inputs cause a
balanced moderate inhibition of the GPe, which in turn inhibits
STN. The STN reduces excitation of the GPi, which disinhibits the
thalamus. Additionally, these combined inputs would facilitate a
release of the thalamus through the direct pathway, illustrated
in Figure 3. Based on this model, we would expect dampening
of the STN during implicit memory tasks in healthy patients.
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Specifically, we theorize that the GABA concentration within
the STN would increase as a result of cortical stimulation of
the striatum and subsequent inhibition of the GPe. This would
remove the STN’s stimulatory effect on the GPi to further inhibit
thalamo-cortical circuits. The net effect would be activation or
disinhibition of thalamocortical circuits.
In PD patients during an implicit memory task (Figure 4),
the lack of dopaminergic input does not provide the previously
described selective amplifying effect to the excitatory thalamo-
cortical projections. Thus, cortico-striatal excitation provides
nonselective stimulation, resulting in further inhibition of the
GPe through the indirect path and, most likely, a much smaller
amount of inhibition of the GPi through the direct pathway.
In turn, GABA was predicted to be decreased in the STN. The
GPi would experience the summative effect of inhibition from
the striatum and GPi as well as diffuse stimulation from the
STN. Since the STN is already hyperactive, we predicted any
marginal increase in activity would dominate the inputs of the
GPi, resulting in inhibition of the thalamus.
Thalamic inhibition by the GPi would release excitatory effer-
ent projections to the STN, reducing glutamate. Simultaneously,
compensatory hyperdirect stimulation of the STN would cease,
possibly also reducing the relative glutamate concentration. Our
data demonstrates reduced levels of GABA and glutamate during
the WPT, which is in agreement with our predictions.
LIMITATIONS
As our understanding of BG circuitry and dynamics continues
to evolve, the interdependence of sub-cortical and cortical con-
nectivity and interaction in the context of learning and memory
makes experimental predictions difficult and uncertain. In light of
this dynamic field, our predictions for the relative concentrations
of GABA and glutamate within the STN are only hypotheses.
While our experimental setup with the WPT did produce statisti-
cally significant changes, the temporal limitations of microdialysis
and a more nuanced relationship between implicit memory and
the WPT only allow the suggestion of a causal relationship and its
underlying dynamic.
FUTURE DIRECTIONS
In light of these findings, we plan to update our methodology
to examine more specific facets of the neurochemical basis of
habit learning in PD patients. For instance, whether or not
immediate-feedback contingent neurochemical changes during
implicit memory tasks corroborate the behavioral deficit that is
observed when PD patients are performing WP task needs to be
further tested. We hope to be able to provide clarity between the
pathological basis of PD and BG dynamics. Newer technological
methods may also improve some of the limitations of micro-
dialysis alone and provide mechanisms for rigorous consistency
between overlapping fields, such as memory and learning.
SUMMARY
In summary, through the use of microdialysis, we examined
the relative concentrations of GABA and glutamate within
the STN during declarative memory and feedback-contingent
implicit memory tasks in PD patients. We predicted changes in
neurotransmitter levels within the STN based on newer models of
BG circuitry and a current understanding of Parkinson’s pathol-
ogy. We found no statistically significant changes in GABA or
glutamate during declarative memory tasks, but we did observe
statistically significant reductions in GABA and glutamate during
completion of the WPT. We provide these results as the first
attempt to bring neurochemical measurements of the basal gan-
glia to compare and update current computational and circuit
models of functional activity in Parkinson’s patients.
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